The dual and opposite role of theTM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis-Reference-Cited by-同舟云学术

The dual and opposite role of theTM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis

Published:2015-10-29 Issue:6 Volume:62 Page:1742-1756
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Pirola Carlos J.¹,Sookoian Silvia²

Affiliation:

1. Department of Molecular Genetics and Biology of Complex Diseases, Institute of Medical Research A Lanari-IDIM; University of Buenos Aires-National Scientific and Technical Research Council (CONICET); Ciudad Autónoma de Buenos Aires Argentina

2. Department of Clinical and Molecular Hepatology, Institute of Medical Research A Lanari-IDIM; University of Buenos Aires-National Scientific and Technical Research Council (CONICET); Ciudad Autónoma de Buenos Aires Argentina

Funder

Agencia Nacional de Promoción Científica y Tecnológica

Publisher

Wiley

Subject

Hepatology

Reference42 articles.

1. Heart disease and stroke statistics-2014 update: a report from the American Heart Association;Go;Circulation,2014

2. Major lipids, apolipoproteins, and risk of vascular disease;Di;JAMA,2009

3. Lipid parameters for measuring risk of cardiovascular disease;Arsenault;Nat Rev Cardiol,2011

4. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies;Gami;J Am Coll Cardiol,2007

5. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults;Malik;Circulation,2004

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches;European Journal of Medical Research;2024-03-20

2. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America;Hepatology;2024-02-20

3. Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus;Liver International;2024-01-31

4. Gut microbiota in MAFLD: therapeutic and diagnostic implications;Therapeutic Advances in Endocrinology and Metabolism;2024-01

5. From puzzle pieces to picture: Genetic data helps refine our understanding of the link between liver fat and heart disease risk;Atherosclerosis;2024-01